FDA Hosts Meeting on Safety of Kids Swallowing Fluoride Prescriptions
Published Date: 6/16/2025
Notice
Summary
The FDA is hosting a public meeting to talk about the safety and use of unapproved fluoride medicines kids might take by mouth. They want parents, doctors, and everyone to share their thoughts to help decide what’s best. This is a chance to shape future rules and make sure kids stay safe, with comments open soon and no costs yet.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FDA Seeks Public Input on Oral Fluoride Drugs
The FDA will hold a hybrid public meeting titled "Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population" to get input on clinical use and safety concerns for children. The meeting is being facilitated by the Reagan‑Udall Foundation, and the FDA is establishing a public docket so parents, clinicians, and other stakeholders can submit comments.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
2026-19655, Jeffrey Thies: Final Debarment Order
Jeffrey Thies is banned for 10 years from importing any drugs into the U.S. because he was convicted of trafficking fake drugs. He didn’t respond to the FDA’s notice, so the ban started on September 25, 2026. He can apply to end the ban anytime, but until then, no drug imports for him!
Previous / Next Documents
Previous: 2025-10940, Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company
Some folks want to buy shares in banks or bank companies, and the Federal Reserve is checking their applications to make sure everything’s on the up and up. If you want to share your thoughts, you’ve got until July 1, 2025, to speak up! This process helps keep banks safe and sound while letting new owners step in smoothly.
Next: 2025-10944, Ripe Olives From Spain: Final Results of Antidumping Duty Administrative Review; 2022-2023
The U.S. checked if some Spanish olive sellers sold their ripe olives for less than fair prices between August 2022 and July 2023. They found that some did, so extra duties (taxes) will apply to those imports. This means importers might pay more money, and sellers need to watch for updates on these changes.